COSCIENS Biopharma Inc. (LON: 0UGB)

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.87M USD in the quarter ending September 30, 2024, with 62,266.67% growth. This brings the company's revenue in the last twelve months to $4.83M, down -25.23% year-over-year. In the year 2023, COSCIENS Biopharma had annual revenue of $4.50M, down -20.25%.

• Revenue (ttm): $4.83M
• Revenue Growth: -25.23%
• P/S Ratio: n/a
• Revenue / Employee: $402.83K
• Employees: 12
• Market Cap: 8.55M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.50M	-1.14M	-20.25%
Dec 31, 2022	5.64M	380.00K	7.22%
Dec 31, 2021	5.26M	1.61M	44.03%
Dec 31, 2020	3.65M	3.12M	586.47%
Dec 31, 2019	532.00K	-26.35M	-98.02%